SAUMX
Price
$37.57
Change
-$0.00 (-0.00%)
Updated
Jul 31 closing price
Net Assets
342.19M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

SAUMX vs VSCIX

SAUMX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
SAUMX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SAUMX is a Buy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. SAUMX (342M). VSCIX pays higher dividends than SAUMX: VSCIX (1.23) vs SAUMX (0.45). SAUMX was incepted earlier than VSCIX: SAUMX (27 years) vs VSCIX (29 years). SAUMX (0.89) is less costly to investors than VSCIX (0.03). VSCIX is a more actively managed with annual turnover of: 17.00 vs. SAUMX (3.00). SAUMX has a lower initial minimum investment than VSCIX: SAUMX (100000) vs VSCIX (5000000). SAUMX annual gain was more profitable for investors over the last year : 26.99 vs. VSCIX (22.58). VSCIX return over 5 years is better than : 35.13 vs. SAUMX (14.50).
SAUMXVSCIXSAUMX / VSCIX
Total Expense Ratio0.890.032,967%
Annual Report Gross Expense Ratio0.890.032,967%
Fund Existence27 years29 years-
Gain YTD18.10814.591124%
Front LoadN/AN/A-
Min. Initial Investment10000050000002%
Min. Initial Investment IRAN/AN/A-
Net Assets342M189B0%
Annual Yield % from dividends0.451.2336%
Returns for 1 year26.9922.58119%
Returns for 3 years43.9543.44101%
Returns for 5 years14.5035.1341%
Returns for 10 years67.28156.0743%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C